Oxidative Stress Regulates Glycogen Synthase Kinase-3 in Lymphocytes of Diabetes Mellitus Patients Complicated with Cerebral Infarction

Overview

Journal Open Med (Wars)

Specialty General Medicine

Date 2024 Dec 10

PMID 39655056

Authors

Man Wang

Ying Qu

Shujin Wang

Zhongsen Qu

Affiliations

Soon will be listed here.

Abstract

Objective: To explore the role of oxidative stress on glycogen synthase kinase-3 in lymphocytes of diabetes mellitus (DM) patients complicated with cerebral infarction (CI).

Materials And Methods: A total of 186 DM patients were enrolled according to the inclusion criteria and exclusion criteria, including 89 DM patients alone (DM group) and 97 DM patients with CI (DM + CI) group. Eighty-one patients with CI were selected as the CI group, and 80 normal subjects over 50 years were selected as the control group. Superoxide dismutase (SOD) activity, glutathione peroxidase (GSH-Px) activity, and malondialdehyde (MDA) content in serum were determined by colorimetric assays. Phosphorylation of GSK-3β was measured by enzyme-linked immunosorbent assay.

Results: (1) Compared with the control group, the SOD and GSH-Px activities in the DM group and DM + CI group were decreased, accompanied by higher MDA content. Furthermore, phosphorylation of GSK-3β was decreased. (2) In the DM + CI group, SOD activity was decreased on days 7 and 10 and month 3 compared to the CI group and was decreased on day 7 compared to the DM group. MDA content was increased from day 0 to month 3 compared to the CI group. On days 1, 7, and 10, GSH-Px activity was lower than the DM group, and on day 10 and month 3, it was lower than the CI group. Phosphorylation of GSK-3β was decreased on days 7 and 10 compared to the DM group and was decreased from day 1 to month 3 compared to the CI group.

Conclusion: In the present study, we demonstrated that the oxidative stress in peripheral lymphocytes of DM patients complicated with CI was stronger, and the GSK-3 activity was higher. It suggested that oxidative stress might enhance the GSK-3 activity, which might provide a diagnostic and therapeutic approach for DM complicated with CI, and targeting GSK-3 is a promising therapeutic target for the treatment of type 2 diabetes and its complications.

References

Skrha Jr J . Diabetes, Lipids, and CV Risk. Curr Atheroscler Rep. 2021; 23(3):8. DOI: 10.1007/s11883-021-00905-8. View

Majidi Z, Hosseinkhani S, Amiri-Dashatan N, Emamgholipour S, Tutunchi S, Hashemi J . Effect of rosiglitazone on circulating malondialdehyde (MDA) level in diabetes based on a systematic review and meta-analysis of eight clinical trials. J Investig Med. 2021; 69(3):697-703. DOI: 10.1136/jim-2020-001588. View

Taheri R, Mokhtari Y, Yousefi A, Bashash D . The PI3K/Akt signaling axis and type 2 diabetes mellitus (T2DM): From mechanistic insights into possible therapeutic targets. Cell Biol Int. 2024; 48(8):1049-1068. DOI: 10.1002/cbin.12189. View

Yaribeygi H, Sathyapalan T, Atkin S, Sahebkar A . Molecular Mechanisms Linking Oxidative Stress and Diabetes Mellitus. Oxid Med Cell Longev. 2020; 2020:8609213. PMC: 7085395. DOI: 10.1155/2020/8609213. View

Rehman K, Akash M . Mechanism of Generation of Oxidative Stress and Pathophysiology of Type 2 Diabetes Mellitus: How Are They Interlinked?. J Cell Biochem. 2017; 118(11):3577-3585. DOI: 10.1002/jcb.26097. View

Zhang L, Yang M, Wang Z, Fan D, Shen F, Zou X . Sevoflurane postconditioning ameliorates cerebral hypoxia/reoxygenation injury in zebrafish involving the Akt/GSK-3β pathway activation and the microtubule-associated protein 2 promotion. Biomed Pharmacother. 2024; 175:116693. DOI: 10.1016/j.biopha.2024.116693. View

Deng R, Zhou J . The role of PI3K/AKT signaling pathway in myocardial ischemia-reperfusion injury. Int Immunopharmacol. 2023; 123:110714. DOI: 10.1016/j.intimp.2023.110714. View

Srivani G, Sharvirala R, Veerareddy P, Pal D, Kiran G . GSK-3 Inhibitors as New Leads to Treat Type-II Diabetes. Curr Drug Targets. 2021; 22(13):1555-1567. DOI: 10.2174/1389450122666210120144428. View

Balbaa M, Abdulmalek S, Khalil S . Oxidative stress and expression of insulin signaling proteins in the brain of diabetic rats: Role of Nigella sativa oil and antidiabetic drugs. PLoS One. 2017; 12(5):e0172429. PMC: 5432169. DOI: 10.1371/journal.pone.0172429. View

10.

Zhang L, Wu Y, Qiu L, Liu Y, Li Q . Elevated Levels of Serum β2-Glycoprotein I/Oxidized Low-Density Lipoprotein Complexes Are Associated with Cerebral Infarction in Patients with Type 2 Diabetes Mellitus. Med Sci Monit. 2018; 24:1232-1240. PMC: 5841189. DOI: 10.12659/msm.907078. View

11.

Chaudhary M, Chaudhary S, Sharma Y, Singh T, Mishra A, Sharma S . Aging, oxidative stress and degenerative diseases: mechanisms, complications and emerging therapeutic strategies. Biogerontology. 2023; 24(5):609-662. DOI: 10.1007/s10522-023-10050-1. View

12.

Powers W, Rabinstein A, Ackerson T, Adeoye O, Bambakidis N, Becker K . 2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2018; 49(3):e46-e110. DOI: 10.1161/STR.0000000000000158. View

13.

Li H, Zhang C, Zhou Y, Deng Y, Zheng X, Xue X . Neurovascular protection of alisol A on cerebral ischemia mice through activating the AKT/GSK3β pathway. Aging (Albany NY). 2023; 15(20):11639-11653. PMC: 10637819. DOI: 10.18632/aging.205151. View

14.

An Y, Xu B, Wan S, Ma X, Long Y, Xu Y . The role of oxidative stress in diabetes mellitus-induced vascular endothelial dysfunction. Cardiovasc Diabetol. 2023; 22(1):237. PMC: 10475205. DOI: 10.1186/s12933-023-01965-7. View

15.

Galea I . The blood-brain barrier in systemic infection and inflammation. Cell Mol Immunol. 2021; 18(11):2489-2501. PMC: 8481764. DOI: 10.1038/s41423-021-00757-x. View

16.

Teli D, Gajjar A . Glycogen synthase kinase-3: A potential target for diabetes. Bioorg Med Chem. 2023; 92:117406. DOI: 10.1016/j.bmc.2023.117406. View

17.

Black H . A Synopsis of the Associations of Oxidative Stress, ROS, and Antioxidants with Diabetes Mellitus. Antioxidants (Basel). 2022; 11(10). PMC: 9598123. DOI: 10.3390/antiox11102003. View

18.

. The Prevention of Diabetes Mellitus. JAMA. 2021; 325(2):190. DOI: 10.1001/jama.2020.17738. View

19.

Chen Y, Li B, Li K, Lin Y . Superoxide dismutase nanozymes: current status and future perspectives on brain disease treatment and diagnosis. Chem Commun (Camb). 2024; 60(31):4140-4147. DOI: 10.1039/d3cc06288k. View

20.

Wang J, Wang A, He H, She X, He Y, Li S . Trametenolic acid B protects against cerebral ischemia and reperfusion injury through modulation of microRNA-10a and PI3K/Akt/mTOR signaling pathways. Biomed Pharmacother. 2019; 112:108692. DOI: 10.1016/j.biopha.2019.108692. View